SILO · SILO Pharma Inc
United States · RS rating 54 · As of 2026-11-03
| Price | 1.28 USD |
|---|---|
| 1-day change | +5.8% |
| RS rating (overall / 1M / 3M / 12M) | 54 / 28 / 4 / 96 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 35 / 51 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +57.8% |
| Sales growth Q/Q | +0.0% |
| Distance from 52-week high | +83.4% |
| Market cap (USD) | $7.7M |